对脑髓母细胞瘤复发的机制性见解
Kendell Peterson1, Maria Turos-Cabal1, April D Salvador1
1Darby Children's Research Institute, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.
Pharmacology & therapeutics
|June 10, 2024
概括
儿科大脑瘤,特别是脑髓母细胞瘤 (MB),对于复发病例需要新的治疗方法. 了解治疗失败的分子驱动因素是为MB儿童开发个性化治疗的关键.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经瘤学神经瘤学
- 癌症分子生物学分子生物学
背景情况:
- 脑髓母细胞瘤 (MB) 是儿童中最常见的恶性脑瘤,也是癌症相关死亡的主要原因.
- 现在MB被分为四个不同的分子子组,帮助临床试验分层和治疗开发.
- 尽管取得了进展,但大约30%的MB患者出现瘤复发,这种复发通常是转移性的,对当前的治疗反应不佳.
研究的目的:
- 审查了解儿科脑髓母细胞瘤治疗失败和复发的分子机制的最新进展.
- 提出这些分子见解如何为新诊断和复发性MB提供个性化医疗信息.
- 讨论正在进行的治疗策略,强调MB的子组特定方法.
主要方法:
- 关于脑髓母细胞瘤治疗失败和复发的最新研究的文献综述.
- 分析治疗耐药性和疾病复发背后的分子机制.
- 综合发现,为个性化医疗策略和当前治疗评估提供信息.
主要成果:
- 最近的进展改善了对MB分子子组的理解,但治疗失败和复发仍然是重大挑战.
- 正在阐明导致MB治疗耐药性和复发的分子机制.
- 针对特定MB子组的个性化医疗方法正在研究中.
结论:
- 迫切需要新的治疗策略来解决复发性脑髓母细胞瘤的不良预后.
- 了解治疗失败的分子驱动因素对于开发有效,个性化的儿科MB治疗方法至关重要.
- 目前正在进行的研究重点是针对新诊断的和复发性脑髓母细胞瘤的子组特异性治疗方法.
相关概念视频
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:20The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K